The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
if anyone is interested...
You will find our stated intention clearly repeated; Directors shall do the most value accretive deal for the company, the project is such that it could be profitably developed as a stand alone but JV/Offtake finance and sale options all being seriously considered. What you will never hear us say is that Toral is up for sale and that is the only way we are going to go because that would be very stupid.
Mining licence- we have a very strong dialogue with the Junta of Castilla y Leon and their support of us, and indeed our delivery of work stated, is one of the strongest parts of Toral. Will update as we go but in the mean time met test and ore sorting progressing well and will update on how we have cut the budgets further, while still being able to do good work, shortly.
Noticed the bid has been ticking up on small sells, hopefully we can get going soon
To be honest, all I wanted to know is why news flow is so slow when there's allegedly so much going on.
Granted some info is price sensitive which the company aren't going to release without an RNS but you can at least keep active with press releases and interviews etc. if you google the company name the last news article anywhere is a month old. If you go on the company website the RNS from the 16th April isn't even on the announcements. An investor going on the website sees... mets delayed until early April... then nothing and we're in mid May. Doesn't look very good or professional.
And what happened to the mining licence? Company employed in September 2018 to take 18 months so would be March 20. Policy was changed in the region so that work wasn't required anymore but what happened? Are we still progressing? Are we close?
I'm here for the asset because that's what I believe in, but trying to get anything out the company is like pulling teeth.
There's 3... and one of them is for 20 odd quid.
Had to pay full ask at 24 but put it through as an NT trade, couldn't get a live price.
As well grab a few more while its quiet... very quiet
Why is one person in twitter getting so much recognition? I believe in my decisions and I back myself, not someone on Twitter I don’t know and couldn’t pick out in a line up.
I suggest some others do the same.
She’d, I’ve always found AIM a little disappointing on genuine news. It gets momentum on potential and you see a huge rise but then when actual news lands not much happens.
I’m hoping LR has kept potential away from the market here and for once we get what we deserve on the end game.
I mentioned the other day I’m playing around with Covid shares, the majority of those have nothing of any substance, only a market that is desperate for results and away they go.
It’s a strange old place the AIM market.
Paraytec were given a grant to work with Aptamers in 2013 as the below.
This isn’t a new area for them, they’ve been working in this field for years.
Novel Use of Aptamers and UV Area Imaging for Disease Detection
Innovate UK award to Paraytec Limited and Mark Vaux
We're way behind on market cap just for the tests, then add in 50% of a sanitiser business which to be fair, working in construction, I might as well be showering in the stuff...
We know where demand is going for these companies... just got to wait it out.